Table 3.
Multivariate analysis of OS and CSS for patients with hepatic vascular tumor (HMVT)
| Categories | AS (N=350) | EHE (N=114) | HMVT-all (N=510) | HMVT-training (N=308) | ||||
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| P-value, HR (95% CI) | ||||||||
|
| ||||||||
| OS | CSS | OS | CSS | OS | CSS | OS | CSS | |
| Age | ||||||||
| <40 | reference | reference | reference | reference | ||||
| 40-59 | 0.240, 1.33 (0.83-2.16) | 0.554, 1.17 (0.70-1.96) | 0.548, 1.28 (0.57-2.91) | 0.965, 0.98 (0.40-2.38) | 0.119. 1.34 (0.93-1.94) | 0.287, 1.24 (0.84-1.84) | 0.063, 1.57 (0.98-2.59) | 0.224, 1.37 (0.82-2.28) |
| ≥60 | <0.001, 2.46 (1.54-3.92) | 0.014, 1.87 (1.13-3.08) | <0.001, 5.41 (2.41-12.16) | 0.003, 3.91 (1.59-9.63) | <0.001, 3.09 (2.14-4.46) | <0.001, 2.49 (1.68-3.71) | <0.001, 3.27 (2.03-5.19) | 0.002, 2.27 (1.36-3.78) |
| Sex | ||||||||
| female | reference | reference | reference | reference | ||||
| male | 0.043, 1.24 (0.97-1.57) | 0.042, 1.33 (1.01-1.74) | 0.116, 1.18 (0.96-1.46) | 0.030, 1.30 (1.03-1.65) | 0.155, 1.22 (0.93-1.60) | 0.119, 1.28 (0.94-1.75) | ||
| Grade | ||||||||
| low-grade | reference | reference | reference | reference | ||||
| high-grade | 0.072, 6.62 (0.85-51.86) | 0.023, 1.78 (1.08-2.91) | 0.042, 1.77 (1.02-3.08) | 0.089, 1.75 (0.92-3.32) | 0.137, 1.75 (0.84-3.68) | |||
| Fibrosis | ||||||||
| none to moderate | reference | reference | reference | reference | ||||
| severe | 0.311, 1.64 (0.63-4.24) | 0.973, 0.98 (0.27-3.55) | 0.009, 17.92 (2.04-157.43) | 0.009, 30.33 (2.38-386.40) | 0.334, 1.49 (0.66-3.34) | 0.567, 1.37 (0.47-3.97) | 0.363, 0.55 (0.15-2.01) | |
| Tumor number | ||||||||
| 1 | reference | reference | reference | reference | ||||
| ≥2 | 0.921, 0.00 (0.00-infinite) | 0.917, 0.00 (0.00-0.005) | 0.935, 0.00 (0.00-infinite) | |||||
| Tumor size | ||||||||
| ≤5 cm | reference | reference | reference | reference | ||||
| >5 cm | 0.595, 1.18 (0.64-2.16) | 0.964, 0.98 (0.45-2.15) | 0.016, 0.24 (1.30-12.91) | 0.009, 6.47 (1.61-26.06) | 0.039, 1.55 (0.97-2.50) | 0.003, 2.38 (133-4.26) | 0.009, 2.21 (1.22-4.000) | 0.043, 2.21 (1.02-4.44) |
| Surgery | ||||||||
| Yes | reference | reference | reference | reference | ||||
| No | 0.022, 2.16 (1.12-4.17) | 0.047, 2.08 (1.01-4.27) | ||||||
| Chemotherapy | ||||||||
| Yes | reference | reference | reference | reference | ||||
| No | 0.021, 1.48 (1.06-2.06) | 0.023, 1.54 (1.06-2.22) | ||||||
| Histological type | ||||||||
| AS | reference | reference | ||||||
| HE | <0.001, 0.47 (0.31-0.71) | 0.001, 0.46 (0.28-0.74) | 0.004, 0.45 (0.26-0.77) | 0.001, 0.34 (0.18-0.66) | ||||
| EHE | <0.001, 0.30 (0.22-0.41) | <0.001, 0.30 (0.21-0.43) | <0.001, 0.27 (0.18-0.41) | <0.001, 0.23 (0.14-0.38) | ||||
| HP | 0.131, 0.58 (0.28-1.18) | 0.314, 0.65 (0.28-1.50) | 0.086, 0.41 (0.15-1.14) | 0.185, 0.45 (0.14-1.47) | ||||
| T stage | ||||||||
| early stage | reference | reference | reference | reference | ||||
| advanced stage | 0.059, 0.54 (0.28-1.02) | 0.044, 2.77 (1.03-7.44) | 0.201, 2.19 (0.66-7.32) | 0.041, 1.50 (1.02-2.20) | 0.128, 1.42 (0.90-2.22) | 0.464, 1.21 (0.73-1.99) | 0.891, 1.05 (0.55-1.97) | |
| N stage | ||||||||
| N0 | reference | reference | reference | reference | ||||
| N1 | 0.232, 2.48 (0.56-11.02) | |||||||
| M stage | ||||||||
| M0 | reference | reference | reference | reference | ||||
| M1 | 0.110, 1.31 (0.94-1.84) | 0.072, 1.43 (0.97-2.10) | 0.028, 2.34 (1.10-4.98) | 0.039, 2.81 (1.06-7.47) | ||||